NCT00549640 - Testing Methylphenidate for Smoking Abstinence | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

May 31, 2009

Conditions

Smoking

Interventions

DRUG

Methylphenidate

54 mg Methylphenidate per day for 8 weeks. Allowing for a ramp up in the first two weeks (starting dose is 18 mg/day).

DRUG

Placebo

non-active (sugar pill)designed to be a look-alike to the methylphenidate. Given at the same frequency and dosage look-alike to the active comparator (methylphenidate 54 mg)

Trial Locations (1)

55905

Mayo Clinic, Rochester